C
C4X Discovery
C4X Discovery - building the world's most productive drug discovery engine
About C4X Discovery
C4X Discovery is a pioneering biotechnology company specializing in the discovery and development of small molecule drugs targeting immuno-inflammatory diseases. The company leverages advanced bioinformatics and cutting-edge technologies to identify and develop novel therapeutic candidates. C4X Discovery primarily serves pharmaceutical companies and healthcare providers, operating within the biopharmaceutical market. The business model revolves around early-stage drug discovery and development, which involves identifying potential drug candidates and advancing them through preclinical and early clinical stages. Revenue is generated through licensing agreements, collaborations, and milestone payments from pharmaceutical partners. The company’s multidisciplinary team combines expertise in biology, chemistry, and computational science to drive innovation and deliver impactful solutions.
Source: Dealroom company dataAt a glance
- Founded
- 2007
- Headquarters
- Manchester, United Kingdom
- Listing
- IPO 2014
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Calculus Capital
Polar Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about C4X Discovery on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See C4X Discovery on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.